Power Up: CELFX’s $1.175 Billion Credit Surge for Thriving Expansion
CELFX secures $1.175 billion credit facility to fuel growth and expand assets. Discover how this boost enhances their investment strategy.
Massive $12M Boost: Eupraxia’s Funding Fuels Breakthrough Drug Research
Eupraxia Pharmaceuticals has secured a $12M loan to advance drug innovations and ensure financial stability through 2025. Learn how this funding fuels their breakthrough treatments.
Big $8.2 Billion Bunge-Viterra Deal Delayed: Key Concerns and Approvals Needed
The $8.2 billion Bunge-Viterra deal is delayed due to pending approvals from China, Canada, and the EU, as regulators review antitrust concerns.
Transformational Deal: BNP Paribas’ $5.5B Acquisition of Axa’s Investment Division to Revolutionize Asset Management
BNP Paribas is acquiring Axa's investment division for €5.5B, creating a major asset management player with €1,500B under management.